Key result
Oxidized phospholipids accelerate calcific aortic valve disease by up-regulating ATF4 to promote osteogenic differentiation.
Why the study?
The study sought to analyze the role of oxidized phospholipid in the progression of calcific aortic valve disease with the involvement of activating transcription factor 4.
Oxidized phospholipids accelerate calcific aortic valve disease by up-regulating ATF4 via the PERK/eIF2α pathway, promoting M1 macrophage polarization and osteogenic differentiation of valvular interstitial cells.
Hypothesis-generating for oxidized phospholipid targeting in calcific aortic valve disease; prospective human studies required before clinical consideration.
In this study we sought to analyze the critical role of oxidized phospholipid (OxPL) in the progression of calcific aortic valve disease (CAVD) with the involvement of activating transcription factor 4 (ATF4). Differentially expressed genes related to CAVD were identified using bioinformatics analysis. Expression of ATF4 was examined in mouse models of aortic valve calcification (AVC) induced by the high cholesterol (HC) diet. Valvular interstitial cells (VICs) were then isolated from mouse non-calcified valve tissues, induced by osteogenic induction medium (OIM) and co-cultured with OxPAPC-stimulated macrophages. The effect of OxPLs regulating ATF4 on the macrophage polarization and osteogenic differentiation of VICs was examined with gain- and loss-of-function experiments in VICs and in vivo. In aortic valve tissues and OIM-induced VICs, ATF4 was highly expressed. ATF4 knockdown alleviated the osteogenic differentiation of VICs, as evidenced by reduced expression of bone morphogenetic protein-2 (BMP2), osteopontin (OPN), and osteocalcin. In addition, knockdown of ATF4 arrested the AVC in vivo. Meanwhile, OxPL promoted M1 polarization of macrophages and mediated osteogenic differentiation of VICs. Furthermore, OxPL up-regulated ATF4 expression through protein kinase R-like endoplasmic reticulum kinase (PERK)/eukaryotic translation initiation factor 2 subunit alpha (eIF2α) pathway. In conclusion, OxPL can potentially up-regulate the expression of ATF4, inducing macrophages polarized to M1 phenotype, osteogenic differentiation of VICs and AVC, thus accelerating the progression of CAVD.
No takes yet. Share an insight, caveat, or question.
Zhu et al. (2023) studied Calcific aortic valve disease. Oxidized phospholipids (OxPL) and ATF4 knockdown was evaluated on Osteogenic differentiation of valvular interstitial cells and aortic valve calcification. Oxidized phospholipids up-regulate ATF4 expression via the PERK/eIF2α pathway, promoting M1 macrophage polarization and osteogenic differentiation to accelerate calcific aortic valve disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: